In a finding that broadens our understanding of how the immune system can detect infection, researchers have identified a previously unappreciated way in which bacteria can be recognized inside our cells.
Many bacteria cause disease by invading cells and creating a safe niche in which to replicate. Cells respond to the infection by activating the immune system, and a chief challenge for bacteria is to avoid immune detection. Prior research had shown that bacteria inside the cytosol (the cells expansive gel-like compartment) could be detected, but how bacteria within the cytosol are recognized has not been clear.
In the new work, Dr. John Brumell and colleagues at The Hospital for Sick Children studied the fate of Salmonella bacteria within the cytosol. These bacteria normally occupy vacuoles in host cells, but under some conditions they leave the vacuole and enter the cytosol. In this foreign environment, the bacteria were recognized by the ubiquitin system, a protein machine that applies molecular tags to cellular proteins to target them for destruction by the proteasome, essentially a molecular shredding device inside mammalian cells. These findings suggest that bacterial proteins are being destroyed by the proteasome within the cytosol during infection, and that this may play a key role in activation of the immune system. A surprising result came when Salmonella was compared with Listeria, a bacterium which normally occupies the cytosol. Listeria avoided recognition by the ubiquitin system by moving within this compartment. This suggests that Listeria and other bacteria that can colonize the cytosol do so in a manner that prevents activation of the immune system.
Heidi Hardman | EurekAlert!
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences